(AVXC) Avantis Emerging Markets - Overview
Etf: Technology, Financials, Consumer, Materials, Energy
Dividends
| Dividend Yield | 2.11% |
| Yield on Cost 5y | 2.57% |
| Yield CAGR 5y | 89.88% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 15.3% |
| Relative Tail Risk | 4.80% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.03 |
| Alpha | 32.52 |
| Character TTM | |
|---|---|
| Beta | 0.658 |
| Beta Downside | 0.635 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.44% |
| CAGR/Max DD | 1.08 |
Description: AVXC Avantis Emerging Markets January 17, 2026
AVXC is a U.S.- domiciled exchange-traded fund that commits at least 80 % of its capital to equity securities of companies operating in emerging-market economies, explicitly excluding firms incorporated in China. The manager’s definition of “emerging market” follows the standard classification that any country not listed as “developed” by the IMF is eligible.
Key quantitative traits (as of the most recent filing) include an expense ratio of roughly 0.45 % and total assets under management near $1.2 billion. The portfolio is heavily weighted toward India (≈30 % of net assets) and Brazil (≈12 %), reflecting their large domestic consumption bases and relatively higher GDP growth forecasts (≈6–7 % YoY for India in 2025). Sector exposure is dominated by financials and consumer discretionary, which benefit from rising middle-class income and ongoing financial inclusion initiatives. These drivers are supported by base-rate data: emerging-market GDP growth averaged 5.2 % over the past decade, outpacing the 2.1 % average in developed economies.
For a deeper, data-driven look at AVXC’s risk-adjusted performance, you might explore ValueRay’s analytics.
What is the price of AVXC shares?
Over the past week, the price has changed by +2.30%, over one month by +7.15%, over three months by +15.98% and over the past year by +43.88%.
Is AVXC a buy, sell or hold?
What are the forecasts/targets for the AVXC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 82.7 | 16.5% |
AVXC Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 245.1m USD (245.1m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 245.1m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 245.1m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.34% (E(245.1m)/V(245.1m) * Re(8.34%) + (debt-free company))
Discount Rate = 8.34% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)